Elevance Health (ELV) Earnings Analysis

Elevance Health (ELV) next reports earnings on 2026-10-20, consensus EPS 4.79 USD. Last quarter (2026-07-15) it beat with EPS 7.45 USD vs 6.21 USD est (+20%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E 17.29.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ELV next report earnings?

Next earnings date2026-10-20
Consensus EPS estimate4.79 USD
Revenue estimate49.26B

ELV earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-157.45 USD6.21 USD+20%Beat
2026-04-2212.58 USD10.82 USD+16.3%Beat
2026-01-283.33 USD3.1 USD+7.4%Beat
2025-10-216.03 USD4.93 USD+22.3%Beat
2025-07-178.84 USD8.91 USD-0.8%Miss
2025-01-233.84 USD3.8 USD+1.1%Beat
2024-10-178.37 USD9.66 USD-13.4%Miss

Beat rate: 5/7 (71%) over reported quarters with consensus data.

ELV valuation and analyst view

Trailing P/E17.29
Trailing EPS22.777 USD
Price / book1.89
Dividend yield1.76%
Market cap84.11B
Analyst consensusBuy (27 buy / 11 hold / 0 sell)
Avg price target444.29 USD

Related research pages

Frequently asked questions

When is Elevance Health (ELV)'s next earnings date?

Elevance Health is next scheduled to report on 2026-10-20, with a consensus EPS estimate of 4.79 USD and revenue estimate of 49.26B.

Did ELV beat earnings last quarter?

In its 2026-07-15 report, ELV posted EPS of 7.45 USD versus a 6.21 USD estimate — a beat of 20%.

What is ELV's earnings track record?

Over the last 7 reported quarters with consensus data, ELV beat estimates 5 times (71%).

What is ELV's current P/E ratio and EPS?

ELV trades at a trailing P/E of 17.29 on trailing EPS of 22.776502983019732 USD.

What do analysts rate ELV?

Analyst consensus is "Buy" across 38 ratings (0 strong buy, 27 buy, 11 hold, 0 sell, 0 strong sell). Average 12-month price target: 444.29 USD.